论文部分内容阅读
目的研究骨混合移植(MBT)法治疗良性骨肿瘤的疗效及对并发症的影响,为临床治疗提供指导依据。方法选择2011年2月至2014年2月接受手术治疗的99例良性骨肿瘤患者的临床资料进行回顾性分析,根据手术方案分为MBT组52例,自体骨移植(ABT)组47例。术后随访1年,比较两组的疗效、手术及并发症情况。结果MBT组的优良率显著高于ABT组(80.77%vs 61.70%,P<0.05);手术时间、术中出血量、愈合时间、住院时间均显著少于ABT组(P均<0.01)。两组患者骨性融合率相近(P>0.05)。MBT组排异反应发生率为5.77%,与ABT组的10.64%相比差异无统计学意义(P>0.05);并发症发生率显著低于ABT组(21.15%vs 72.34%,P<0.01)。结论 MBT法对于良性骨肿瘤患者的疗效更佳,利于愈合,效果显著。
Objective To study the effect of bone mixed transplantation (MBT) on the treatment of benign bone tumors and its impact on the complications, so as to provide guidance for clinical treatment. Methods The clinical data of 99 patients with benign bone tumors undergoing surgery from February 2011 to February 2014 were retrospectively analyzed. According to the surgical plan, 52 patients were divided into MBT group and 47 patients received autologous bone graft (ABT). The patients were followed up for 1 year. The curative effect, operation and complication of the two groups were compared. Results The excellent and good rate of MBT group was significantly higher than that of ABT group (80.77% vs 61.70%, P <0.05). The operation time, intraoperative blood loss, healing time and hospital stay were significantly less than those in ABT group (all P <0.01). Bone fusion rate was similar between the two groups (P> 0.05). The incidence of rejection in MBT group was 5.77%, which was not significantly different from that in ABT group (P> 0.05). The incidence of complications was significantly lower than that in ABT group (21.15% vs 72.34%, P <0.01) . Conclusion The MBT method is more effective in patients with benign bone tumors, which is beneficial to healing and has a significant effect.